ANI Pharmaceuticals | ANIP - Net Income

Stock Price
76.82
Daily Change
0.12 0.16%
Monthly
-5.55%
Yearly
39.65%
Q1 Forecast
75.36

ANI Pharmaceuticals reported $26.27M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
ANI Pharmaceuticals USD 26.27M 18.13M Sep/2025
Assertio Holdings USD -2.92M 753K Sep/2024
Aurora Cannabis CAD -51.47M 36.26M Sep/2025
Canopy Growth CAD -1.64M 39.89M Sep/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Emergent BioSolutions USD -261.3M 78.3M Jun/2023
Heron Therapeutics USD -4.85M 4.39M Sep/2024
Hikma Pharmaceutical USD 119M 14M Jun/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Novartis USD 3.93B 113M Sep/2025
Omeros USD -32.23M 23.81M Sep/2024
Perrigo USD 7.5M 15.9M Sep/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025